You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

VIOXX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Vioxx patents expire, and when can generic versions of Vioxx launch?

Vioxx is a drug marketed by Merck and is included in two NDAs.

The generic ingredient in VIOXX is rofecoxib. There are two drug master file entries for this compound. Additional details are available on the rofecoxib profile page.

US Patents and Regulatory Information for VIOXX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck VIOXX rofecoxib SUSPENSION;ORAL 021052-001 May 20, 1999 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Merck VIOXX rofecoxib TABLET;ORAL 021042-002 May 20, 1999 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Merck VIOXX rofecoxib SUSPENSION;ORAL 021052-002 May 20, 1999 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Merck VIOXX rofecoxib TABLET;ORAL 021042-001 May 20, 1999 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Merck VIOXX rofecoxib TABLET;ORAL 021042-003 Feb 25, 2000 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VIOXX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck VIOXX rofecoxib TABLET;ORAL 021042-002 May 20, 1999 ⤷  Try a Trial ⤷  Try a Trial
Merck VIOXX rofecoxib TABLET;ORAL 021042-001 May 20, 1999 ⤷  Try a Trial ⤷  Try a Trial
Merck VIOXX rofecoxib SUSPENSION;ORAL 021052-001 May 20, 1999 ⤷  Try a Trial ⤷  Try a Trial
Merck VIOXX rofecoxib TABLET;ORAL 021042-001 May 20, 1999 ⤷  Try a Trial ⤷  Try a Trial
Merck VIOXX rofecoxib TABLET;ORAL 021042-002 May 20, 1999 ⤷  Try a Trial ⤷  Try a Trial
Merck VIOXX rofecoxib TABLET;ORAL 021042-003 Feb 25, 2000 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for VIOXX

See the table below for patents covering VIOXX around the world.

Country Patent Number Title Estimated Expiration
Japan H08504408 ⤷  Try a Trial
Canada 2278241 HETEROCYCLES PHENYLIQUES, INHIBITEURS DE LA CYCLOOXYGENASE-2 (PHENYL HETEROCYCLES AS CYCLOOXYGENASE-2 INHIBITORS) ⤷  Try a Trial
Slovakia 284330 ⤷  Try a Trial
Canada 2202173 ⤷  Try a Trial
Japan 3720634 ⤷  Try a Trial
Hungary 9601875 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.